The Market for Pediatric Drugs In India Is Expected to cross INR 960 Billion in the Future: Ken Research - PowerPoint PPT Presentation

About This Presentation
Title:

The Market for Pediatric Drugs In India Is Expected to cross INR 960 Billion in the Future: Ken Research

Description:

The pediatric drugs market in India grew at a staggering CAGR of ~% during the period FY'2011-FY'2016 exhibiting the annual revenue of INR ~ billion in FY'2011 which inclined to INR ~ billion in FY'2016. – PowerPoint PPT presentation

Number of Views:49

less

Transcript and Presenter's Notes

Title: The Market for Pediatric Drugs In India Is Expected to cross INR 960 Billion in the Future: Ken Research


1
The Market for Pediatric Drugs In India Is
Expected to cross INR 960 Billion in the Future
Ken Research
2
India pediatric drugs and vaccine market has
witnessed tremendous growth in the last five
years largely due to high number of annual births
recorded at around 25 million, launch of generic
formulations of several pediatric drugs including
flavored TB drugs, inclusion of several vaccines
in the national immunization schedule of the
country and inclining coverage of children
vaccination under national immunization schedule.
3
In the last few years, medium to large Indian
pharmaceutical companies have aggressively
invested in international acquisition of
companies to strengthen their foothold in
developed and emerging markets globally. Indias
healthcare spending is one of the lowest in the
world with the country spending only 1.2 of its
GDP on health care as compared to 8.3 by the US
and global mean of 5.4, as of FY2016. It also
has the highest infant mortality rate and
maternal mortality rate in the world. This has
propelled the pharmaceutical industry to address
the existing unmet challenges. The industry has
come out with drug formulations for infants
against some life threatening diseases such as
tuberculosis and pneumonia which has helped to
curb down the infant mortality rate in the
country.
4
The market for pediatric drugs and vaccines in
India is almost entirely driven by companies
manufacturing generic drugs. Almost all
pharmaceutical companies operating in the country
have expertise in developing generic drugs
formulations of branded drugs developed by
international companies so as to cater with
underprivileged populations at a much cheaper
price. India has a huge disease burden and a
large part of drugs sold in the country is meant
for the treatment of several infectious and
non-infectious diseases prevalent in the
pediatric population. Pediatric drug are commonly
used for diarrheal diseases such as cholera and
viral gastroenteritis. Respiratory diseases
including pneumonia and tuberculosis are other
commonly treatable conditions for which drugs
find extensive usage in the country.
5
Anti-infectives were the most frequently
prescribed drug class by pediatricians, with over
80 of the prescriptions had some form of
prescribed antibiotics. This is due to the wide
scale prevalence of children being affected by
respiratory diseases or some sort of microbial
infections at regular basis. India has emerged
as leading vaccine producer in the world, in
terms of doses of vaccines produced, and has
about 12 major vaccine manufacturing facilities
across the country. Vaccines manufactured in
these facilities are offered in both national and
international market (over 150 countries). With
over 25 million births every year, the domestic
market for vaccines in India is huge. The country
has been self sufficient in meeting the domestic
needs, with private sector responsible for
providing a large part of the supply needs.
6
Key Factors Considered in the Report Pediatric
Drug Development Trends Pediatric Vaccine
Market Number Of Pediatrician Statistics Pediatric
Tuberculosis Drug Market Drug Information,
Dosage, Side Effects Vaccines Market Growth
India Drug Pipeline Pediatric Drug Vaccine
Clinical Trials India Pediatric Drug Market
Industry Size New Drug Launches India Pharma
Sector Pediatric Vaccine Serum Institute Of India
7
For more information on the market research
report please refer to the below
link https//www.kenresearch.com/healthcare/phar
maceuticals/india-pediatric-drug-vaccine-market/81
319-91.html Contact Us Ken ResearchAnkur
Gupta, Head Marketing CommunicationsAnkur_at_kenre
search.com91-9015378249
8
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com